|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net income/(loss) | |||||
| Adjustments to reconcile net loss to cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Share-based compensation | |||||
| Services paid in common stock | |||||
| Stock issued for warrant settlement | |||||
| Stock issued for services | |||||
| Gain on lease modification | |||||
| Loss on disposal of assets | |||||
| Amortization of debt discount | |||||
| Operating lease asset amortization | |||||
| Loss on equity method investment | |||||
| Patent write off | |||||
| Inventory write off and reserve expense | |||||
| Inventory reserve expense | |||||
| Gain on settlement of liabilities, net | |||||
| Gain on Swiss liabilities (Note 5) | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable | |||||
| Related party payable | |||||
| Operating lease liabilities | |||||
| Accrued interest | |||||
| Accrued expenses | |||||
| Net cash (used in) operating activities | |||||
| Investing Activities: | |||||
| Purchase of property, plant and equipment | |||||
| Patent activity costs | |||||
| Purchase of cost investment | |||||
| Net cash provided by (used in) investing activities | |||||
| Financing Activities: | |||||
| Proceeds from issuance of Series 1C Preferred Stock | |||||
| Payment of convertible debt and conversions payable | |||||
| Proceeds from bridge loans | |||||
| Repayment of bridge loans | |||||
| Payment of Series 1B Preferred Stock | |||||
| Proceeds from issuance of stock and warrants | |||||
| Financing issuance cost | |||||
| Warrant repurchase | |||||
| Exercise of warrants | |||||
| Payment of convertible notes, cash payable, and other payable | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of foreign exchange rate on cash | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Cash paid for interest | |||||
| Non-Cash Transactions: | |||||
| Conversions of preferred stock, convertible notes, and conversions payable to equity | |||||
| Series 1A preferred stock conversion | |||||
| Extinguishment of note payable | |||||
| Exercise of prefunded warrants | |||||
| Purchase and return of equipment purchased on credit | |||||
| Conversion of prefunded warrants | |||||
| Down round deemed dividend | |||||
| Series 1C conversions | |||||
Loading...